Grand Pharma
Grand Pharma (also known as Grand Pharmaceutical Group Limited) is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1998, the company has made significant strides in the development, manufacturing, and distribution of innovative healthcare solutions across various operational regions, including Asia and beyond. Specialising in prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, Grand Pharma distinguishes itself through its commitment to quality and research-driven approaches. The company has achieved notable milestones, including strategic partnerships and a robust portfolio of unique products that cater to diverse therapeutic areas. With a strong market position, Grand Pharma is recognised for its contributions to healthcare, consistently striving to enhance patient outcomes and expand its global footprint.
DitchCarbon Score
How does Grand Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Grand Pharma's score of 22 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Grand Pharma's reported carbon emissions
In 2021, Grand Pharma reported significant carbon emissions totalling approximately 172,000,000 kg CO2e for Scope 1 and about 104,000,000 kg CO2e for Scope 2. This brings their total emissions from these two scopes to around 276,000,000 kg CO2e. Notably, there is no available data on Scope 3 emissions. Currently, Grand Pharma has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. This lack of defined climate commitments may reflect broader industry trends, where many companies are still in the early stages of establishing comprehensive climate strategies. As a company headquartered in China, Grand Pharma's emissions data highlights the importance of addressing carbon outputs in the pharmaceutical sector, particularly as global attention on climate change intensifies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 172,000,000 |
| Scope 2 | 104,000,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Grand Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
